Lincoln Pharmaceuticals Limited
Lincoln Pharmaceuticals Ltd. is an India-based company, engaged in the business of manufacturing, marketing and exports of pharmaceutical products. The Company operates primarily in pharmaceutical and chemical segments. The company is in the business of manufacturing and marketing of pharmaceuticals products and trading in finished goods, chemicals products and bulk drug. The Company’s geographical segment includes domestic and export sales. The Company’s manufacturing facility at Khatraj, Gujarat. The Company’s Khatraj Plant produces only non betalactum tablets, capsules, liquid and drypowder, injectables, syrups.
To know more about the products of LPL please check this web site
Total Debt is also reducing which is a positive sign.
Company is also working on capacity expansion, setting up a beta-lactum antibiotics manufacturing plant to cater to increasing international demand.
Earning per share of the company for the earnings for FY16 and FY17 is expected to be around Rs 11 and 13 respectively.
The Indian pharmaceutical industry is expected to post double-digit growth in 2015-16(http://www.thehindu.com/news/cities/mumbai/pharma-sector-in-healthy-growth/article7019490.ece)
As pharma sector is growing in india, LML is having a better opportunity for growth.
One can analyse further & decide on investing around Rs 100-120/. CMP is Rs 136.60/- hence keep monitoring this stock & can invest during correction.
If you are not a long term investor then don’t invest in this stock.